Department of Oral Diagnostics, Digital Health and Health Services Research, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute of AI and Health Policy (BAIP), Charité - Universitätsmedizin Berlin, Germany.
Department of Oral Diagnostics, Digital Health and Health Services Research, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute of AI and Health Policy (BAIP), Charité - Universitätsmedizin Berlin, Germany.
J Dent. 2020 Aug;99:103417. doi: 10.1016/j.jdent.2020.103417. Epub 2020 Jun 24.
To assess if long-term treatment costs in periodontitis patients differ between stage III vs. IV and grade B vs. C according to the 2018 classification of periodontal diseases.
A cohort of 231 periodontitis patients (followed over a mean of 18.4 years) was evaluated. Costs for active periodontal therapy (APT, including scaling and root planning, open flap debridement, root resections) and supportive periodontal therapy (SPT, including also restorative, endodontic, prosthetic and surgical treatment) were estimated from a mixed payer-perspective in Germany (in Euro 2020). Multi-dimensional staging and grading was applied. The impact of stage, grade, sex and age on total and annual costs was assessed.
Mean (SD) total and annual treatment costs were 7154 (2554) Euro and 437 (222) Euro. Costs were generated during SPT (92 %) and by periodontal treatment (88 %) and decreased significantly with longer follow-up (p < 0.001). Total costs were 7120 (2692) Euro in stage III (n = 154) vs. 7221 (2271) Euro in stage IV (n = 77; p > 0.05), and 6256 (1605) Euro in grade B (n = 35) vs. 7314 (2660) Euro in grade C (n = 196; p < 0.001). Annual costs were 426 (219) Euro vs. 459 (228) Euro for stage III vs. stage IV (p > 0.05) and 308 (163) Euro vs. 460 (224) Euro for grade B vs. grade C (p < 0.001). Multivariable modelling found grade, but not stage, sex and age significantly associated with costs.
Within the limitations of this study, and in patients with severe periodontitis who were systematically treated long-term, grading, but not staging was associated with costs.
Treatment costs were higher in patients with more progressive periodontitis and were found to decrease during follow-up. Dentists need to consider costs during treatment planning and communication with patients.
根据 2018 年牙周病分类,评估牙周炎患者的 III 期 vs. IV 期和 B 级 vs. C 级的长期治疗成本是否存在差异。
对 231 名牙周炎患者(平均随访 18.4 年)进行评估。从德国的混合支付者角度(欧元 2020 年)估算了牙周炎治疗的积极治疗(APT,包括刮治和根面平整、翻瓣清创术、根面切除术)和辅助治疗(SPT,包括修复、牙髓、修复和手术治疗)的成本。采用多维分期和分级。评估了分期、分级、性别和年龄对总费用和年度费用的影响。
平均(SD)总费用和年度费用分别为 7154(2554)欧元和 437(222)欧元。SPT(92%)和牙周治疗(88%)期间产生费用,随着随访时间的延长,费用显著降低(p < 0.001)。III 期(n=154)的总费用为 7120(2692)欧元,IV 期(n=77;p>0.05)为 7221(2271)欧元,B 级(n=35)为 6256(1605)欧元,C 级(n=196;p<0.001)为 7314(2660)欧元。年度费用为 III 期 426(219)欧元,IV 期 459(228)欧元(p>0.05),B 级 308(163)欧元,C 级 460(224)欧元(p<0.001)。多变量模型发现,分级而不是分期、性别和年龄与费用显著相关。
在这项研究的限制内,在接受长期系统治疗的严重牙周炎患者中,与费用相关的是分级而不是分期。牙医在治疗计划和与患者沟通时需要考虑费用。
在患有更进展性牙周炎的患者中,治疗费用更高,并且在随访期间降低。